Sihuan Pharmaceutical Holdings Group Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sihuan Pharmaceutical Holdings Group Ltd with three other
companies in this sector in CHINA :
Gan & Lee Pharmaceuticals Co Ltd
sales of 2.89 billion Chinese Renmimbi [US$417.16 million]
of which 97%
was Insulin and related products),
Guizhou Bailing Group Pharmaceutical Company Limited
(2.85 billion Chinese Renmimbi [US$410.91 million]
of which 84%
was Industry), and
Zhejiang Hisoar Pharmaceutical Co. Ltd
(2.94 billion Chinese Renmimbi [US$424.00 million]
of which 55%
was Pharmatheutical Industry).
During the year ended December of 2019, sales at
Sihuan Pharmaceutical Holdings Group Ltd were 2.89 billion Chinese Renmimbi (US$416.16 million).
decrease of 1.0%
versus 2018, when the company's sales were 2.92 billion Chinese Renmimbi.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Sihuan Pharmaceutical Holdings Group Ltd had sales
of 3.08 billion Chinese Renmimbi.